This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vincens, J. J. Articles by Herrmann, H. C. Search for Related Content PubMed Articles by Vincens, J. J. Articles by Herrmann, H. C.

(Circulation. 1995;92:137-142.)
© 1995 American Heart Association, Inc.

Articles

Long-term Outcome of Cardiac Surgery in Patients With Mitral Stenosis and Severe Pulmonary Hypertension

Presented in part at the 67th Scientific Sessions of the American Heart Association, Dallas, Tex, November 17, 1994.

James J. Vincens, MD; Dogan Temizer, MD; James R. Post, MD; L. Henry Edmunds, Jr, MD; Howard C. Herrmann, MD

From the University of Pennsylvania Medical Center, Philadelphia.

Correspondence to Howard C. Herrmann, MD, Director, Interventional Cardiology, University of Pennsylvania Medical Center, 3400 Spruce St, 9 Founders Pavilion, Philadelphia, PA 19104.

Background Pulmonary hypertension increases perioperative risk in patients having mitral valve replacement, but most studies have included patients with mixed mitral valve disease and have not examined long-term outcome.

Methods and Results We retrospectively examined the results and predictors of outcome of cardiac surgery in 43 patients (age, 62±13 years [mean±SD]; 81% women) with a primary diagnosis of mitral stenosis and severe pulmonary hypertension (pulmonary artery systolic pressure 60 mm Hg or mean pressure 50 mm Hg). Patients with more than mild mitral regurgitation were excluded. Thirty-eight patients (88%) were in NYHA functional class III or IV, and 11 patients (26%) had an acute presentation requiring urgent surgery. Preoperative hemodynamics demonstrated a mean mitral valve area of 0.7±0.3 cm², mean pulmonary artery pressure of 50±9 mm Hg, and pulmonary artery systolic pressure of 81±18 mm Hg. Other characteristics included right ventricular failure (18 patients), coronary artery disease (16 patients), and critical aortic stenosis (11 patients). Forty patients underwent mitral valve replacement with St Jude prostheses; 3 had open commissurotomy. Additional surgical procedures included aortic valve replacement (42%), coronary artery bypass graft surgery (26%), and tricuspid valvuloplasty (16%). There were 5 perioperative deaths (11.6%), and 7 other patients (16%) had major complications, including reoperation for hemorrhage, stroke, respiratory failure, myocardial infarction, or a >30-day hospitalization. Univariate analysis of demographic, hemodynamic, and operative characteristics identified the following predictors of perioperative death (P<.05): acute presentation, clinical evidence of right ventricular failure, impaired left ventricular ejection fraction, and increased left ventricular diastolic pressure. Predictors of complications (P<.05) were acute presentation, ECG evidence of right ventricular hypertrophy, and elevated right ventricular systolic pressure. Multivariate analysis showed only acute presentation and right ventricular hypertrophy as predictors of perioperative death or major complications, respectively. Five- and 10-year actuarial survivals were 80% and 64%, respectively. The only predictor of long-term mortality was advanced age. Functional NYHA status was improved by one grade or more in 76% of survivors.

Conclusions Patients referred to a tertiary care hospital in the United States with mitral stenosis and severe pulmonary hypertension often have other associated cardiac diseases and comorbid conditions. Cardiac surgery can be successfully performed with an acceptable mortality, and risk factors for poor perioperative outcome can be identified by preoperative clinical characteristics. Younger patients have the best long-term survival, and most survivors experienced long-term improvement in functional status.

Key Words: mitral valve • stenosis • hypertension, pulmonary • surgery

This article has been cited by other articles:

				M. Mubeen, A. K Singh, S. K Agarwal, J. Pillai, S. Kapoor, and A. K Srivastava Mitral Valve Replacement in Severe Pulmonary Arterial Hypertension Asian Cardiovasc Thorac Ann, February 1, 2008; 16(1): 37 - 42. [Abstract] [Full Text] [PDF]